Kirill Dmitriev, CEO of the Russian Direct Investment Fund interview with Times Now
In an exclusive interview with Kirill Dmitriev, CEO, RDIF (Russian Direct Investment Fund), tells Times Now, SputnikV is already available in India. It will be even more available by August-September and widely available after Serum Institute Of India launches its production in September. Kiril Dmitriev also appreciates Serum Institue of India, says, it's a great company as it is the largest manufacturer in the world which India can be proud of. He further adds, SputnikV is an effective vaccine against the mutation of covid-19. The RDIF said the plan is to produce more than 300 million doses of the Sputnik V vaccine in India per year.